Literature DB >> 32484965

ATR inhibition potentiates ionizing radiation-induced interferon response via cytosolic nucleic acid-sensing pathways.

Xu Feng1, Anthony Tubbs2, Chunchao Zhang1, Mengfan Tang1, Sriram Sridharan2, Chao Wang1, Dadi Jiang3, Dan Su1, Huimin Zhang1, Zhen Chen1, Litong Nie1, Yun Xiong1, Min Huang1, André Nussenzweig2, Junjie Chen1.   

Abstract

Mechanistic understanding of how ionizing radiation induces type I interferon signaling and how to amplify this signaling module should help to maximize the efficacy of radiotherapy. In the current study, we report that inhibitors of the DNA damage response kinase ATR can significantly potentiate ionizing radiation-induced innate immune responses. Using a series of mammalian knockout cell lines, we demonstrate that, surprisingly, both the cGAS/STING-dependent DNA-sensing pathway and the MAVS-dependent RNA-sensing pathway are responsible for type I interferon signaling induced by ionizing radiation in the presence or absence of ATR inhibitors. The relative contributions of these two pathways in type I interferon signaling depend on cell type and/or genetic background. We propose that DNA damage-elicited double-strand DNA breaks releases DNA fragments, which may either activate the cGAS/STING-dependent pathway or-especially in the case of AT-rich DNA sequences-be transcribed and initiate MAVS-dependent RNA sensing and signaling. Together, our results suggest the involvement of two distinct pathways in type I interferon signaling upon DNA damage. Moreover, radiation plus ATR inhibition may be a promising new combination therapy against cancer.
© 2020 The Authors.

Entities:  

Keywords:  ATR; MAVS; cGAS/STING; radiation; type I interferon

Mesh:

Substances:

Year:  2020        PMID: 32484965      PMCID: PMC7361286          DOI: 10.15252/embj.2019104036

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  48 in total

1.  Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216.

Authors:  C Y Peng; P R Graves; R S Thoma; Z Wu; A S Shaw; H Piwnica-Worms
Journal:  Science       Date:  1997-09-05       Impact factor: 47.728

2.  Novel small-molecule inhibitors of RNA polymerase III.

Authors:  Liping Wu; Jing Pan; Vala Thoroddsen; Deborah R Wysong; Ronald K Blackman; Christine E Bulawa; Alexandra E Gould; Timothy D Ocain; Lawrence R Dick; Patrick Errada; Patrick K Dorr; Tanya Parkinson; Tony Wood; Daniel Kornitzer; Ziva Weissman; Ian M Willis; Karen McGovern
Journal:  Eukaryot Cell       Date:  2003-04

3.  Catastrophic nuclear envelope collapse in cancer cell micronuclei.

Authors:  Emily M Hatch; Andrew H Fischer; Thomas J Deerinck; Martin W Hetzer
Journal:  Cell       Date:  2013-07-03       Impact factor: 41.582

4.  Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint.

Authors:  Q Liu; S Guntuku; X S Cui; S Matsuoka; D Cortez; K Tamai; G Luo; S Carattini-Rivera; F DeMayo; A Bradley; L A Donehower; S J Elledge
Journal:  Genes Dev       Date:  2000-06-15       Impact factor: 11.361

5.  STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors.

Authors:  Liufu Deng; Hua Liang; Meng Xu; Xuanming Yang; Byron Burnette; Ainhoa Arina; Xiao-Dong Li; Helena Mauceri; Michael Beckett; Thomas Darga; Xiaona Huang; Thomas F Gajewski; Zhijian J Chen; Yang-Xin Fu; Ralph R Weichselbaum
Journal:  Immunity       Date:  2014-11-06       Impact factor: 31.745

6.  STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors.

Authors:  Seng-Ryong Woo; Mercedes B Fuertes; Leticia Corrales; Stefani Spranger; Michael J Furdyna; Michael Y K Leung; Ryan Duggan; Ying Wang; Glen N Barber; Katherine A Fitzgerald; Maria-Luisa Alegre; Thomas F Gajewski
Journal:  Immunity       Date:  2014-11-05       Impact factor: 31.745

Review 7.  Regulation of type I interferon responses.

Authors:  Lionel B Ivashkiv; Laura T Donlin
Journal:  Nat Rev Immunol       Date:  2014-01       Impact factor: 53.106

8.  Genome-wide Identification of Structure-Forming Repeats as Principal Sites of Fork Collapse upon ATR Inhibition.

Authors:  Nishita Shastri; Yu-Chen Tsai; Suzanne Hile; Deondre Jordan; Barrett Powell; Jessica Chen; Dillon Maloney; Marei Dose; Yancy Lo; Theonie Anastassiadis; Osvaldo Rivera; Taehyong Kim; Sharvin Shah; Piyush Borole; Kanika Asija; Xiang Wang; Kevin D Smith; Darren Finn; Jonathan Schug; Rafael Casellas; Liliya A Yatsunyk; Kristin A Eckert; Eric J Brown
Journal:  Mol Cell       Date:  2018-10-04       Impact factor: 17.970

9.  cGAS surveillance of micronuclei links genome instability to innate immunity.

Authors:  Karen J Mackenzie; Paula Carroll; Carol-Anne Martin; Olga Murina; Adeline Fluteau; Daniel J Simpson; Nelly Olova; Hannah Sutcliffe; Jacqueline K Rainger; Andrea Leitch; Ruby T Osborn; Ann P Wheeler; Marcin Nowotny; Nick Gilbert; Tamir Chandra; Martin A M Reijns; Andrew P Jackson
Journal:  Nature       Date:  2017-07-24       Impact factor: 49.962

10.  PARP1 depletion induces RIG-I-dependent signaling in human cancer cells.

Authors:  Rajib Ghosh; Sanchita Roy; Sonia Franco
Journal:  PLoS One       Date:  2018-03-28       Impact factor: 3.240

View more
  34 in total

1.  ATR inhibition potentiates ionizing radiation-induced interferon response via cytosolic nucleic acid-sensing pathways.

Authors:  Xu Feng; Anthony Tubbs; Chunchao Zhang; Mengfan Tang; Sriram Sridharan; Chao Wang; Dadi Jiang; Dan Su; Huimin Zhang; Zhen Chen; Litong Nie; Yun Xiong; Min Huang; André Nussenzweig; Junjie Chen
Journal:  EMBO J       Date:  2020-06-02       Impact factor: 11.598

Review 2.  Targeting the DNA damage response in immuno-oncology: developments and opportunities.

Authors:  Roman M Chabanon; Mathieu Rouanne; Christopher J Lord; Jean-Charles Soria; Philippe Pasero; Sophie Postel-Vinay
Journal:  Nat Rev Cancer       Date:  2021-08-10       Impact factor: 60.716

Review 3.  Targeting oncogene and non-oncogene addiction to inflame the tumour microenvironment.

Authors:  Giulia Petroni; Aitziber Buqué; Lisa M Coussens; Lorenzo Galluzzi
Journal:  Nat Rev Drug Discov       Date:  2022-03-15       Impact factor: 84.694

Review 4.  Radiotherapy as a tool to elicit clinically actionable signalling pathways in cancer.

Authors:  Giulia Petroni; Lewis C Cantley; Laura Santambrogio; Silvia C Formenti; Lorenzo Galluzzi
Journal:  Nat Rev Clin Oncol       Date:  2021-11-24       Impact factor: 66.675

5.  ATR-mediated CD47 and PD-L1 up-regulation restricts radiotherapy-induced immune priming and abscopal responses in colorectal cancer.

Authors:  Rodney Cheng-En Hsieh; Sunil Krishnan; Ren-Chin Wu; Akash R Boda; Arthur Liu; Michelle Winkler; Wen-Hao Hsu; Steven Hsesheng Lin; Mien-Chie Hung; Li-Chuan Chan; Krithikaa Rajkumar Bhanu; Anupallavi Srinivasamani; Ricardo Alexandre De Azevedo; Yung-Chih Chou; Ronald A DePinho; Matthew Gubin; Eduardo Vilar; Chao Hsien Chen; Ravaen Slay; Priyamvada Jayaprakash; Shweta Mahendra Hegde; Genevieve Hartley; Spencer T Lea; Rishika Prasad; Brittany Morrow; Coline Agnes Couillault; Madeline Steiner; Chun-Chieh Wang; Bhanu Prasad Venkatesulu; Cullen Taniguchi; Yon Son Betty Kim; Junjie Chen; Nils-Petter Rudqvist; Michael A Curran
Journal:  Sci Immunol       Date:  2022-06-10

6.  Effective Radiosensitization of Bladder Cancer Cells by Pharmacological Inhibition of DNA-PK and ATR.

Authors:  Ahmed Ali Chughtai; Julia Pannhausen; Pia Dinger; Julia Wirtz; Ruth Knüchel; Nadine T Gaisa; Michael J Eble; Michael Rose
Journal:  Biomedicines       Date:  2022-05-30

7.  Paclitaxel Induces Micronucleation and Activates Pro-Inflammatory cGAS-STING Signaling in Triple-Negative Breast Cancer.

Authors:  Yang Hu; Baraa K Manasrah; Stephanie M McGregor; Robert F Lera; Roshan X Norman; John B Tucker; Christina M Scribano; Rachel E Yan; Mouhita Humayun; Kari B Wisinski; Amye J Tevaarwerk; Ruth M O'Regan; Lee G Wilke; Beth A Weaver; David J Beebe; Ning Jin; Mark E Burkard
Journal:  Mol Cancer Ther       Date:  2021-09-28       Impact factor: 6.261

Review 8.  Angiogenesis and immune checkpoint dual blockade in combination with radiotherapy for treatment of solid cancers: opportunities and challenges.

Authors:  Lingling Zhu; Xianzhe Yu; Li Wang; Jiewei Liu; Zihan Qu; Honge Zhang; Lu Li; Jiang Chen; Qinghua Zhou
Journal:  Oncogenesis       Date:  2021-07-10       Impact factor: 7.485

Review 9.  The Replication Stress Response on a Narrow Path Between Genomic Instability and Inflammation.

Authors:  Hervé Técher; Philippe Pasero
Journal:  Front Cell Dev Biol       Date:  2021-06-25

Review 10.  The abscopal effect: a sense of DNA damage is in the air.

Authors:  Timothy P Lippert; Roger A Greenberg
Journal:  J Clin Invest       Date:  2021-05-03       Impact factor: 19.456

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.